Table 1.
Parameter | # of Patients (% of Total) |
---|---|
Total CKD5-HD patients | 90 |
HF (+) CKD5-HD patients | 33 (37%) |
Female CKD5-HD patients | 17 (19%) |
Male CKD5-HD patients | 16 (18%) |
Age, range (mean) | 40-87 years (63.8 years) |
β–Blockers | 53 (58%) |
ACE inhibitors | 18 (20%) |
Aspirin | 42 (46.7%) |
Insulin | 36 (40%) |
Antiplatelets | 12 (13%) |
Statins | 52 (57.8%) |
Atrial fibrillation | 19 (21.1%) |
Anticoagulants | 22 (24.4%) |
Abbreviations: ACE, angiotensin-converting enzyme; CKD5-HD, stage 5 chronic kidney disease hemodialysis; HF, heart failure; LUMC, Loyola University Medical Center.